Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
A Novel Platform for Detection of CK+ and CK− CTCs
2011
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Whether to determine HER2 status for breast cancer in the primary tumour or in the metastasis.
2009
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
2007
Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ
2011
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Breast cancer
2016 Standout
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets
2013
Origins of breast cancer subtypes and therapeutic implications
2007
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Pre-metastatic niches: organ-specific homes for metastases
2017
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
2013
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Gene expression profiling of the tumor microenvironment during breast cancer progression
2009
PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
2014
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
2014
The biology and function of fibroblasts in cancer
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer
2015
Metastasis prevention by targeting the dormant niche
2015
HER2-Positive Circulating Tumor Cells in Breast Cancer
2011
Significance, detection and markers of disseminated breast cancer cells
2006
The landscape of long noncoding RNAs in the human transcriptome
2015 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Shedding light on the cell biology of extracellular vesicles
2018 Standout
<i>TP53</i> Status and Response to Chemotherapy in Breast Cancer
2008
Blinded by the Light: The Growing Complexity of p53
2009 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Cancer micrometastases
2009
Parallel progression of primary tumours and metastases
2009
Emerging Biological Principles of Metastasis
2017 Standout
EMT: 2016
2016 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
HER-2/neu analysis in breast cancer bone metastases
2009
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Dormancy in breast cancer
2012
Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer
2014
Reevaluating response and failure of medical treatment of endometriosis: a systematic review
2017
Clonal evolution in cancer
2012 StandoutNature
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Molecular mechanisms of metastasis in breast cancer—clinical applications
2010
Systemic Spread Is an Early Step in Breast Cancer
2008
Detection, clinical relevance and specific biological properties of disseminating tumour cells
2008
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Technologies for detection of circulating tumor cells: facts and vision
2013
Novel approaches to target the microenvironment of bone metastasis
2021
The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
2011
Harnessing the power of antibodies to fight bone metastasis
2021
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
2015 Standout
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Noncovalent Functionalization of Graphene and Graphene Oxide for Energy Materials, Biosensing, Catalytic, and Biomedical Applications
2016 Standout
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors
2012
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network
2015
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Circulating Tumor Cells in Breast Cancer: Detection Systems, Molecular Characterization, and Future Challenges
2012
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Circulating Tumor Cells in Breast Cancer:Detection Systems, Molecular Characterization, and Future Challenges
2011
Metabolic reprogramming and cancer progression
2020 StandoutScience
Endometriosis
2020 Standout
Tissue preparation for laser capture microdissection and RNA extraction from fresh frozen breast tissue
2007
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
Works of Erich Solomayer being referenced
Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis
2011
Progression-Specific Genes Identified by Expression Profiling of Matched Ductal Carcinomas In situ and Invasive Breast Tumors, Combining Laser Capture Microdissection and Oligonucleotide Microarray Analysis
2006
Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer.
2004
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study
2012
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
2010
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
2007
Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients
2006
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
2006
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
2009
P53 is the strongest predictor of survival in high‐risk primary breast cancer patients undergoing high‐dose chemotherapy with autologous blood stem cell support
2002
Evaluation of a RT-PCR based routine screening tool for the detection of disseminated epithelial cells in the bone marrow of breast cancer patients
2008
Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients
2007
Cytomegalovirus‐specific T cells are detectable in early childhood and allow assignment of the infection status in children with passive maternal antibodies
2012
How can we measure endometriosis-associated pelvic pain?
2012